These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 31807368)

  • 1. Independent Continuing Medical Education (CME)/Continuing Professional Development (CPD) Must Deliver Unbiased Information.
    Guenova M; Schäfer R; Palange P
    J Eur CME; 2019; 8(1):1690321. PubMed ID: 31853422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of accreditation of continuing medical education (CME)-continuing professional development (CPD) in Europe: harmonisation through dialogue and consensus.
    de Andrade F; Griebenow R; Costello RW; Guenova M; Schaefer R; Chalmers JD; Tichelli A; Raguz D; Stein J
    J Eur CME; 2018; 7(1):1506202. PubMed ID: 30206501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commitments by the biopharmaceutical industry to clinical trial transparency: the evolving environment.
    Baronikova S; Purvis J; Southam E; Beeso J; Panayi A; Winchester C
    BMJ Evid Based Med; 2019 Oct; 24(5):177-184. PubMed ID: 30898790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. State of play of CME in Europe in 2015: Proceedings from the Eighth Annual European CME Forum.
    Pozniak E; Jacobson A
    J Eur CME; 2016; 5(1):32174. PubMed ID: 29644124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic Regulatory Assessment: Unpacking the Process Reveals Readiness to Pilot for Europe-An EFPIA View.
    Todd I; Faust R; Herrero-Martinez E; Hussain N; Kawinski A; Lennard A; Roux NL; Macdonald J; Mayer M; Palacios R; Dangy-Caye A
    Clin Ther; 2023 Nov; 45(11):1142-1147. PubMed ID: 37704457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolving role of pharmaceutical physicians in medical evidence and education.
    Setia S; Ryan NJ; Nair PS; Ching E; Subramaniam K
    Adv Med Educ Pract; 2018; 9():777-790. PubMed ID: 30464675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The European Federation of the Pharmaceutical Industry and Associations' Research and Animal Welfare Group: Assessing and benchmarking 'Culture of Care' in the context of using animals for scientific purpose.
    Robinson S; Sparrow S; Williams B; Decelle T; Bertelsen T; Reid K; Chlebus M
    Lab Anim; 2019 Nov; 54(5):23677219887998. PubMed ID: 31744380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Tobacco Industry Has No Business Funding Continuing Medical Education.
    Jackler RK; Ling PM
    JAMA; 2024 Jul; ():. PubMed ID: 38976276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Professional Conferences, Unprofessional Conduct.
    Anand AC
    Med J Armed Forces India; 2011 Jan; 67(1):2-6. PubMed ID: 27365752
    [No Abstract]   [Full Text] [Related]  

  • 10. Risky business? Pharmaceutical industry sponsorship of health consumer groups.
    Bero LA; Parker L
    Aust Prescr; 2021 Jun; 44(3):74-76. PubMed ID: 34211242
    [No Abstract]   [Full Text] [Related]  

  • 11. Centralised Full Access to Clinical Study Data Can Support Unbiased Guideline Development, Continuing Medical Education, and Patient Information.
    McGauran N; Wieseler B
    J Eur CME; 2021; 10(1):1989172. PubMed ID: 34868731
    [No Abstract]   [Full Text] [Related]  

  • 12. Report on Proceedings of the Thirteenth Annual European CME Forum, Held Virtually, November, 2020.
    Murray R
    J Eur CME; 2021; 10(1):1959184. PubMed ID: 34377589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulating for Bias in Medical Education - Reaction to the Pharmaceutical Industry Updated EFPIA Code of Practice.
    Rodzinka M; Seebohm A; Pozniak E; Mosch L; De Luca L; McArdle J; Griebenow R; Velcheva M
    J Eur CME; 2019; 8(1):1685771. PubMed ID: 31807368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transparent collaboration between industry and academia can serve unmet patient need and contribute to reproductive public health.
    D'Hooghe T
    Hum Reprod; 2017 Aug; 32(8):1549-1555. PubMed ID: 28854594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transparency in relations between multinational R&D pharmaceutical companies' corporate social responsibility activities and patient organizations in the Europe, Japan, and the United States].
    Kato M; Ishikawa H; Okuhara T; Kiuchi T
    Nihon Koshu Eisei Zasshi; 2019; 66(12):746-755. PubMed ID: 31875625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Framework for industry engagement and quality principles for industry-provided medical education in Europe.
    Allen T; Donde N; Hofstädter-Thalmann E; Keijser S; Moy V; Murama JJ; Kellner T
    J Eur CME; 2017; 6(1):1348876. PubMed ID: 29644135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between physicians and the pharmaceutical industry: what does the literature say?
    Lexchin J
    CMAJ; 1993 Nov; 149(10):1401-7. PubMed ID: 8221424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Medical Profession, Industry, and Continuing Medical Education: Finding the Balance That's Right for Patients.
    Kearney P; Simoons M; Ryden L; Kirchhof P; Pries A; O'Morain C; Bax JJ
    Am J Med; 2019 Aug; 132(8):921-925. PubMed ID: 30853472
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.